- Why are vegetarians more likely to suffer from depression than meat eaters?
- Small wireless device implanted between skin and skull helps kill cancer cells
- Will the mRNA vaccine that can cure cancer come out near soon?
- Allogeneic T-cell therapy set for landmark first approval
- Boston University denies that the new COVID strain they made has 80% fatality rate
- A new generation of virus-free CAR-T cell therapy
Oxford/AstraZeneca COVID-19 vaccine: one Indian man died
Oxford/AstraZeneca COVID-19 vaccine: one Indian man died. India’s 45-year-old man died after being vaccinated with the COVID-19 vaccine: the second shot, everything was normal before vaccination.
Overseas Network, March 3-On March 2, a 45-year-old man in India became unconscious after receiving the second dose of the “Covishield” COVID-19 vaccine and was declared dead.
According to a report by the Hindustan Times on the 3rd, the deceased Sukhdev Kirdat was a driver of a private doctor and lived in Maharashtra. He was in a coma after being vaccinated at a local vaccination center for 20 minutes. He was rushed to the hospital but was pronounced dead.
This incident caused panic among other vaccinators. City officials claim that the cause of death can only be determined after the autopsy report is released.
The local health official KR Kharat said, “Everything was normal before the deceased was vaccinated, and his body has been sent to the hospital for an autopsy. Experts will study this and submit a cause of death report.
The staff checked all his past Physical condition records. In addition, after the first dose of the deceased was vaccinated, his body was completely normal without any abnormalities.” It is reported that the “Covishield” COVID-19 vaccine was jointly developed by the University of Oxford and AstraZeneca, and was developed by the Serum Institute of India produce
(source:internet, reference only)